A Policy-Driven Perspective on Rising Drug Costs in Dermatology

JAMA Dermatol. 2016 Jun 1;152(6):625-6. doi: 10.1001/jamadermatol.2016.0349.
No abstract available

MeSH terms

  • Cost Control / economics
  • Dermatologic Agents / economics*
  • Drug Costs / trends*
  • Drug Industry / economics*
  • Economic Competition / economics
  • Health Policy / economics*
  • Prescription Fees*
  • United States

Substances

  • Dermatologic Agents